Invention Application
US20160235789A1 Bone Marrow Origin Progenitor Cell or Endothelial Progenitor Cell in Combination with DNMT1 Gene Therapy for Vascular Repair in Metabolic Disease 有权
骨髓原始祖细胞或内皮祖细胞与DNMT1基因治疗代谢疾病血管修复

Bone Marrow Origin Progenitor Cell or Endothelial Progenitor Cell in Combination with DNMT1 Gene Therapy for Vascular Repair in Metabolic Disease
Abstract:
The present invention provides an isolated population of bone marrow-derived endothelial progenitor cells (EPCs) and uses thereof for the treatment of vascular diseases.
Information query
Patent Agency Ranking
0/0